|
1
|
Tao L, Han L, Li X, Gao Q, Pan L, Wu L,
Luo Y, Wang W, Zheng Z and Guo X: Prevalence and risk factors for
cervical neoplasia: A cervical cancer screening program in Beijing.
BMC Public Health. 14:11852014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Snijders PJ, Steenbergen RD, Heideman DA
and Meijer CJ: HPV-mediated cervical carcinogenesis: Concepts and
clinical implications. J Pathol. 208:152–164. 2006. View Article : Google Scholar
|
|
3
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Benedet JL, Bender H, Jones H III and Ngan
HY: FIGO staging classifications and clinical practice guidelines
in the management of gynecologic cancers. Int J Gynaecol Obstet.
70:209–262. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guan P, Howell-Jones R, Li N, Bruni L, de
Sanjosé S, Franceschi S and Clifford GM: Human papillomavirus types
in 115,789 HPV-positive women: A meta-analysis from cervical
infection to cancer. Int J Cancer. 131:2349–2359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Illades-Aguiar B, Cortés-Malagón EM,
Antonio-Véjar V, Zamudio-López N, Alarcón-Romero LC,
Fernández-Tilapa G, Hernández-Sotelo D, Terán-Porcayo MA,
Flores-Alfaro E and Leyva-Vázquez MA: Cervical carcinoma in
Southern Mexico: Human papillomavirus and cofactors. Cancer Detect
Prev. 32:300–307. 2009. View Article : Google Scholar
|
|
7
|
Illades-Aguiar B, Alarcón-Romero LC,
Antonio-Véjar V, Zamudio-López N, Sales-Linares N, Flores-Alfaro E,
Fernández-Tilapa G, Vences-Velázquez A, Muñoz-Valle JF and
Leyva-Vázquez MA: Prevalence and distribution of human
papillomavirus types in cervical cancer, squamous intraepithelial
lesions, and with no intraepithelial lesions in women from Southern
Mexico. Gynecol Oncol. 117:291–296. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kinose Y, Sawada K, Nakamura K and Kimura
T: The role of microRNAs in ovarian cancer. Biomed Res Int.
2014:2493932014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suzuki H, Maruyama R, Yamamoto E and Kai
M: Epigenetic alteration and microRNA dysregulation in cancer.
Front Genet. 4:2582013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lujambio A, Ropero S, Ballestar E, Fraga
MF, Cerrato C, Setién F, Casado S, Suarez-Gauthier A,
Sanchez-Cespedes M, Git A, et al: Genetic unmasking of an
epigenetically silenced microRNA in human cancer cells. Cancer Res.
67:1424–1429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar
|
|
13
|
Gebauer K, Peters I, Dubrowinskaja N,
Hennenlotter J, Abbas M, Scherer R, Tezval H, Merseburger AS,
Stenzl A, Kuczyk MA, et al: Hsa-mir-124-3 CpG island methylation is
associated with advanced tumours and disease recurrence of patients
with clear cell renal cell carcinoma. Br J Cancer. 108:131–138.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uesugi A, Kozaki K, Tsuruta T, Furuta M,
Morita K, Imoto I, Omura K and Inazawa J: The tumor suppressive
microRNA miR-218 targets the mTOR component Rictor and inhibits AKT
phosphorylation in oral cancer. Cancer Res. 71:5765–5778. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rauhala HE, Jalava SE, Isotalo J, Bracken
H, Lehmusvaara S, Tammela TL, Oja H and Visakorpi T: miR-193b is an
epigenetically regulated putative tumor suppressor in prostate
cancer. Int J Cancer. 127:1363–1372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Radpour R, Barekati Z, Kohler C,
Schumacher MM, Grussenmeyer T, Jenoe P, Hartmann N, Moes S, Letzkus
M, Bitzer J, et al: Integrated epigenetics of human breast cancer:
Synoptic investigation of targeted genes, microRNAs and proteins
upon demethylation treatment. PLoS One. 6:e273552011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lodygin D, Tarasov V, Epanchintsev A,
Berking C, Knyazeva T, Körner H, Knyazev P, Diebold J and Hermeking
H: Inactivation of miR-34a by aberrant CpG methylation in multiple
types of cancer. Cell Cycle. 7:2591–2600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suzuki H, Yamamoto E, Nojima M, Kai M,
Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, et al:
Methylation-associated silencing of microRNA-34b/c in gastric
cancer and its involvement in an epigenetic field defect.
Carcinogenesis. 31:2066–2073. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Chen Z, Gao Y, Li N, Li B, Tan F,
Tan X, Lu N, Sun Y, Sun J, et al: DNA hypermethylation of
microRNA-34b/c has prognostic value for stage I non-small cell lung
cancer. Cancer Biol Ther. 11:490–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wilting SM, van Boerdonk RAA, Henken FE,
Meijer CJ, Diosdado B, Meijer GA, le Sage C, Agami R, Snijders PJF
and Steenbergen RD: Methylation-mediated silencing and tumour
suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer.
9:1672010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilting SM, Verlaat W, Jaspers A, Makazaji
NA, Agami R, Meijer CJ, Snijders PJ and Steenbergen RD:
Methylation-mediated transcriptional repression of microRNAs during
cervical carcinogenesis. Epigenetics. 8:220–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Botezatu A, Goia-Rusanu CD, Iancu IV,
Huica I, Plesa A, Socolov D, Ungureanu C and Anton G: Quantitative
analysis of the relationship between microRNA-124a, -34b and -203
gene methylation and cervical oncogenesis. Mol Med Rep. 4:121–128.
2011.PubMed/NCBI
|
|
23
|
Wang X, Wang HK, Li Y, Hafner M, Banerjee
NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, et al: microRNAs
are biomarkers of oncogenic human papillomavirus infections. Proc
Natl Acad Sci USA. 111:4262–4267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et al
Bethesda 2001 Workshop: The 2001 Bethesda System: Terminology for
reporting results of cervical cytology. JAMA. 287:2114–2119. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davis LG, Kuehl WM and Battey JF: Basic
Methods in Molecular Biology. 2nd edition. Appleton and Lange;
Norwalk, CT, pxiv: 1994
|
|
26
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Harris TG, Burk RD, Yu H, Minkoff H,
Massad LS, Watts DH, Zhong Y, Gange S, Kaplan RC, Anastos K, et al:
Insulin-like growth factor axis and oncogenic human papillomavirus
natural history. Cancer Epidemiol Biomarkers Prev. 17:245–248.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kitano K, Watanabe K, Emoto N, Kage H,
Hamano E, Nagase T, Sano A, Murakawa T, Nakajima J, Goto A, et al:
CpG island methylation of microRNAs is associated with tumor size
and recurrence of non-small-cell lung cancer. Cancer Sci.
102:2126–2131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shimizu T, Suzuki H, Nojima M, Kitamura H,
Yamamoto E, Maruyama R, Ashida M, Hatahira T, Kai M, Masumori N, et
al: Methylation of a panel of microRNA genes is a novel biomarker
for detection of bladder cancer. Eur Urol. 63:1091–1100. 2013.
View Article : Google Scholar
|
|
30
|
Suzuki H, Takatsuka S, Akashi H, Yamamoto
E, Nojima M, Maruyama R, Kai M, Yamano HO, Sasaki Y, Tokino T, et
al: Genome-wide profiling of chromatin signatures reveals
epigenetic regulation of MicroRNA genes in colorectal cancer.
Cancer Res. 71:5646–5658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lujambio A, Calin GA, Villanueva A, Ropero
S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso
MS, Faller WJ, et al: A microRNA DNA methylation signature for
human cancer metastasis. Proc Natl Acad Sci USA. 105:13556–13561.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Toyota M, Suzuki H, Sasaki Y, Maruyama R,
Imai K, Shinomura Y and Tokino T: Epigenetic silencing of
microRNA-34b/c and B-cell translocation gene 4 is associated with
CpG island methylation in colorectal cancer. Cancer Res.
68:4123–4132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamamoto N, Kinoshita T, Nohata N, Itesako
T, Yoshino H, Enokida H, Nakagawa M, Shozu M and Seki N: Tumor
suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013.PubMed/NCBI
|
|
34
|
Guan H, Wei G, Wu J, Fang D, Liao Z, Xiao
H, Li M and Li Y: Down-regulation of miR-218-2 and its host gene
SLIT3 cooperate to promote invasion and progression of thyroid
cancer. J Clin Endocrinol Metab. 98:E1334–E1344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar :
|
|
36
|
Li Y, Liu J, Yuan C, Cui B, Zou X and Qiao
Y: High-risk human papillomavirus reduces the expression of
microRNA-218 in women with cervical intraepithelial neoplasia. J
Int Med Res. 38:1730–1736. 2010. View Article : Google Scholar
|
|
37
|
Zhong Q, Wang T, Lu P, Zhang R, Zou J and
Yuan S: miR-193b promotes cell proliferation by targeting Smad3 in
human glioma. J Neurosci Res. 92:619–626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheung TH, Man KN, Yu MY, Yim SF, Siu NS,
Lo KW, Doran G, Wong RR, Wang VW, Smith DI, et al: Dysregulated
microRNAs in the pathogenesis and progression of cervical neoplasm.
Cell Cycle. 11:2876–2884. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu H, Li S, Liu J and Ni B: MicroRNA-193b
modulates proliferation, migration, and invasion of non-small cell
lung cancer cells. Acta Biochim Biophys Sin (Shanghai). 44:424–430.
2012. View Article : Google Scholar
|
|
40
|
Lenarduzzi M, Hui AB, Alajez NM, Shi W,
Williams J, Yue S, O'Sullivan B and Liu FF: MicroRNA-193b enhances
tumor progression via down regulation of neurofibromin 1. PLoS One.
8:e537652013. View Article : Google Scholar : PubMed/NCBI
|
